Was nach HIV-Exposition zu tun ist
Crossref DOI link: https://doi.org/10.1007/s15006-022-0942-8
Published Online: 2022-06-17
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seybold, Ulrich
Text and Data Mining valid from 2022-06-01
Version of Record valid from 2022-06-01
Article History
First Online: 17 June 2022
Interessenkonflikt:
: Vortragstätigkeit: Gilead Sciences, Bristol Myers Squibb, MSD Sharp & Dohme, Janssen Cilag; Beratertätigkeit: ViiV Healthcare, Gilead Sciences